Amgen INC AMGEN ORD (CDI)
Amgen INC AMGEN ORD (CDI)/ US0311621009 /
0R0T
25.04.2024 19:06:01
|
Zm.
-
|
Wolumen |
Bid17:35:23 |
Ask17:35:23 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
268,25USD
|
-
|
2 462 Obrót: 173 778,10 |
-Wolumen Bid: - |
-Wolumen Ask: - |
172,03 mldUSD |
2,70% |
25,49 |
Opis działalności
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Zarząd & Rada nadzorcza
CEO |
Robert Bradway |
Zarząd |
Peter H. Griffith, Annalisa Pizzarello, Anton Rabushka, Arleen Paulino, Darryl Sleep, David A. Piacquad, David M. Reese, Esteban Santos, Gilles Marrache, Ian Thompson, Jean-Charles Soria, Jerry Murry, Jonathan Graham, Judy Gawlik Brown, Lori Johnston, Mark J. Taisey, Mike Zahigian, Murdo Gordon, Nancy Grygiel, Rachna Khosla, Raymond Deshaies, Rob Lenz, Susan Sweeney, Victoria H. Blatter |
Rada nadzorcza |
Robert A. Bradway, Amy E. Miles, Brian J. Druker, Charles M. Holley Jr., Ellen J. Kullman, Greg C. Garland, Michael V. Drake, R. Sanders Williams, Robert A. Eckert, Ronald D. Sugar, S. Omar Ishrak, Tyler Jacks, Wanda M. Austin |
Dane firmy
Nazwa: |
Amgen Inc. |
Adres: |
One Amgen Center Drive,Thousand Oaks, CA 91320-1799, USA |
Telefon: |
+1-805-447-1000 |
Fax: |
+1-805-447-1010 |
E-mail: |
investor.relations@amgen.com
|
Internet: |
www.amgen.com |
Przemysł: |
Służba zdrowia |
Sektor: |
Produkty Medyczne |
Podsektor: |
Zaawansowane Urządzenia Medyczne |
Koniec roku finansowego: |
31.12 |
Free float: |
76,20% |
Data IPO: |
17.06.1983 |
Kalendarz korporacyjny
Tydz. 47 | 18.11.2024
Record Date
|
Tydz. 47 | 18.11.2024
Wcześniejsza dywidenda
|
Tydz. 50 | 09.12.2024
Wypłata Dywidendy
|
Główni akcjonariusze
Inne |
|
71,83% |
Vanguard Group Inc |
|
9,15% |
State Street Corp |
|
5,50% |
Primecap Management Co/Ca/ |
|
2,72% |
Morgan Stanley |
|
2,69% |
Geode Capital Management, Llc |
|
2,30% |
Charles Schwab Investment Management Inc |
|
1,94% |
Wells Fargo & Company/Mn |
|
1,40% |
Capital Research Global Investors |
|
1,25% |
Inne |
|
1,22% |